Anti-GTR9/ GLUT9/ SLC2A9 monoclonal antibody

Anti-GTR9/ GLUT9/ SLC2A9 antibody for FACS & in-vivo assay

Target products collectionGo to GLUT9/SLC2A9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T00523-Ab-1/ GM-Tg-hg-T00523-Ab-2Anti-Human GLUT9/SLC2A9 monoclonal antibodyHuman
GM-Tg-rg-T00523-Ab-1/ GM-Tg-rg-T00523-Ab-2Anti-Rat GLUT9/SLC2A9 monoclonal antibodyRat
GM-Tg-mg-T00523-Ab-1/ GM-Tg-mg-T00523-Ab-2Anti-Mouse GLUT9/SLC2A9 monoclonal antibodyMouse
GM-Tg-cynog-T00523-Ab-1/ GM-Tg-cynog-T00523-Ab-2Anti-Cynomolgus/ Rhesus macaque GLUT9/SLC2A9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T00523-Ab-1/ GM-Tg-felg-T00523-Ab-2Anti-Feline GLUT9/SLC2A9 monoclonal antibodyFeline
GM-Tg-cang-T00523-Ab-1/ GM-Tg-cang-T00523-Ab-2Anti-Canine GLUT9/SLC2A9 monoclonal antibodyCanine
GM-Tg-bovg-T00523-Ab-1/ GM-Tg-bovg-T00523-Ab-2Anti-Bovine GLUT9/SLC2A9 monoclonal antibodyBovine
GM-Tg-equg-T00523-Ab-1/ GM-Tg-equg-T00523-Ab-2Anti-Equine GLUT9/SLC2A9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T00523-Ab-1/ GM-Tg-hg-T00523-Ab-2; GM-Tg-rg-T00523-Ab-1/ GM-Tg-rg-T00523-Ab-2;
GM-Tg-mg-T00523-Ab-1/ GM-Tg-mg-T00523-Ab-2; GM-Tg-cynog-T00523-Ab-1/ GM-Tg-cynog-T00523-Ab-2;
GM-Tg-felg-T00523-Ab-1/ GM-Tg-felg-T00523-Ab-2; GM-Tg-cang-T00523-Ab-1/ GM-Tg-cang-T00523-Ab-2;
GM-Tg-bovg-T00523-Ab-1/ GM-Tg-bovg-T00523-Ab-2; GM-Tg-equg-T00523-Ab-1/ GM-Tg-equg-T00523-Ab-2
Products NameAnti-GLUT9/SLC2A9 monoclonal antibody
Formatmab
Target NameGLUT9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GLUT9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GTR9/ GLUT9/ SLC2A9 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000084human SLC2A9 Lentivirus particle
    ORF Viral VectorpGMLV000084human SLC2A9 Lentivirus plasmid
    ORF Viral VectorpGMLPm005348mouse Slc2a9 Lentivirus plasmid
    ORF Viral VectorvGMLPm005348mouse Slc2a9 Lentivirus particle


    Target information

    Target IDGM-T00523
    Target NameGLUT9
    Gene ID56606,117591,501925,712922,479093,101089609,100337051,100056219
    Gene Symbol and SynonymsGLUT-9,GLUT9,GLUTX,SLC2A9,SLC2a9A,SLC2A9B,UAQTL2,URATv1
    Uniprot AccessionQ9NRM0
    Uniprot Entry NameGTR9_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000109667
    Target ClassificationN/A

    The target: GLUT9, gene name: SLC2A9, also named as GLUT9, GLUTX, UAQTL2, URATv1. This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.